Board Meeting23 Mar 2026, 01:12 pm

Jenburkt Pharmaceuticals Ltd Closes Trading Window as per SEBI Regulations

AI Summary

Jenburkt Pharmaceuticals Limited has announced the closure of the trading window for all designated persons, insiders, and connected persons, including their relatives, as per the SEBI(Prohibition of Insider Trading) Regulations, 2015. The closure will be in effect from 1st April, 2026, until 48 hours after the standalone audited financial results for the quarter and financial year ending on 31st March, 2026, are disseminated or made public. The Company will inform the exchange about the schedule of the Board Meeting for considering the said audited financial results separately.

Key Highlights

Jenburkt Pharmaceuticals Limited closes trading window as per SEBI regulations.
The closure is effective from 1st April, 2026.
The closure applies to all designated persons, insiders, and connected persons, including their relatives.
The closure will last until 48 hours after the standalone audited financial results are made public.
The Company will inform the exchange about the Board Meeting schedule separately.

View BSE Filing

JENBURPH*

Pharmaceuticals

JENBURKT PHARMACEUTICALS LTD.

Price Impact